selenocysteine has been researched along with Breast Neoplasms in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 9 (56.25) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 3 (18.75) | 2.80 |
Authors | Studies |
---|---|
Flowers, B; Kastrati, I; Poles, A | 1 |
Alorda-Clara, M; Moran, C; Oliver, J; Pons, DG; Roca, P; Sastre-Serra, J | 1 |
Carlisle, AE; Doshi, MB; Greer, PL; Joseph, AB; Kim, D; Lee, N; Li, R; Matthew-Onabanjo, AN; Park, SJ; Peppers, A; Shaw, LM; Simin, K; Smith, M; Spears, ME; Youkana, D; Zhu, LJ | 1 |
Burke, TR; Hazlehurst, L; Hymel, D; Li, X; Martinez-Acedo, P; Moroni, T; Nair, RR; Nanna, AR; Nelson, CG; Rader, C | 1 |
Chen, PC; Guo, CH; Hsia, S; Hsieh, FC; Shih, MY | 1 |
Gangapurkar, B; Jariwalla, RJ; Nakamura, D | 1 |
Baker, MV; Barnard, PJ; Berners-Price, SJ; Filipovska, A; Hickey, JL; Ruhayel, RA | 1 |
Belame, A; Burow, ME; Carrier, L; Li, Z; Rowan, BG; Salvo, VA; Thiyagarajah, A | 1 |
Zarbl, H; Zhang, X | 1 |
Chen, T; Li, M; Li, X; Liu, C; Liu, Z; Ngai, SM; Wong, YS; Zhang, Y; Zheng, W | 1 |
Conklin, D; Millar, RP; Morgan, K; Ott, TR; Pawson, AJ; Sellar, R | 1 |
Chen, PL; Desai, KV; Furuta, S; Green, JE; Jiang, X; Lee, WH; Levin, DS; Utomo, A; Wang, YC; Yun, J | 1 |
Crowell, JA; Johnson, WD; Kapetanovic, I; McCormick, DL; Morrissey, RL | 1 |
Jiao, NL; Wang, J; Zheng, J | 1 |
Ganther, H; Ip, C; Medina, D; Thompson, H | 1 |
Boylan, LM; Spallholz, JE; Yan, L; Yee, JA | 1 |
1 review(s) available for selenocysteine and Breast Neoplasms
Article | Year |
---|---|
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Cysteine; Disease Models, Animal; Female; Humans; Mammary Neoplasms, Experimental; Organoselenium Compounds; Selenocysteine; Treatment Outcome | 2001 |
15 other study(ies) available for selenocysteine and Breast Neoplasms
Article | Year |
---|---|
Selenium and breast cancer - An update of clinical and epidemiological data.
Topics: Breast Neoplasms; Female; Humans; Polymorphism, Single Nucleotide; Selenium; Selenocysteine; Selenoproteins | 2022 |
Micronutrients Selenomethionine and Selenocysteine Modulate the Redox Status of MCF-7 Breast Cancer Cells.
Topics: Antioxidants; Breast Neoplasms; Cell Survival; Female; Humans; Hydrogen Peroxide; Lipid Metabolism; MCF-7 Cells; Micronutrients; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Selenocysteine; Selenomethionine; Uncoupling Protein 2 | 2020 |
Selenium detoxification is required for cancer-cell survival.
Topics: Amino Acid Transport System y+; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Ferroptosis; Humans; Inactivation, Metabolic; Mice; Mice, Nude; Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Phosphotransferases; Selenium; Selenium Compounds; Selenocysteine; Xenograft Model Antitumor Assays | 2020 |
Stable and Potent Selenomab-Drug Conjugates.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Fluorescein; Humans; Immunoconjugates; Interleukin Receptor Common gamma Subunit; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Pharmaceutical Preparations; Protein Stability; Receptor, ErbB-2; Selenocysteine; Syndecan-1; Transplantation, Heterologous | 2017 |
Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Glutathione Peroxidase; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Organoselenium Compounds; Oxidative Stress; Reactive Oxygen Species; Selenium; Selenocysteine; Superoxide Dismutase; Yeasts | 2015 |
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms | 2009 |
Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cysteine; Drug Design; Drug Screening Assays, Antitumor; Gold; Heterocyclic Compounds; Humans; Methane; Mitochondria; Mitochondrial Proteins; Organometallic Compounds; Selenocysteine; Thioredoxin-Disulfide Reductase | 2008 |
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Cyclin D1; Cysteine; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Organoselenium Compounds; Random Allocation; Receptors, Progesterone; Selenocysteine; Specific Pathogen-Free Organisms; Tamoxifen; Xenograft Model Antitumor Assays | 2009 |
Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Cycle Proteins; Chemoprevention; Circadian Rhythm; Cysteine; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Glands, Animal; Methylnitrosourea; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Organoselenium Compounds; Period Circadian Proteins; Rats; Rats, Inbred F344; Selenium; Selenocysteine; Specific Pathogen-Free Organisms | 2008 |
Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
Topics: Antineoplastic Agents; Apoptosis; Auranofin; Breast Neoplasms; DNA Damage; Drug Synergism; Enzyme Inhibitors; Humans; MCF-7 Cells; Mitogen-Activated Protein Kinases; Molecular Targeted Therapy; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Selenocysteine; Thioredoxin-Disulfide Reductase; Tumor Suppressor Protein p53 | 2013 |
A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12.
Topics: Adenoma; Alternative Splicing; Amino Acid Sequence; Animals; Blotting, Northern; Breast Neoplasms; Callithrix; Choriocarcinoma; Chromosomes, Human, Pair 1; DNA, Antisense; Endometrial Neoplasms; Evolution, Molecular; Female; Humans; Jurkat Cells; Male; Molecular Sequence Data; Neuroblastoma; Nucleic Acid Conformation; Open Reading Frames; Phylogeny; Pituitary Neoplasms; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; Selenocysteine; Sequence Homology, Nucleic Acid; Transcriptional Activation | 2003 |
Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells.
Topics: Amino Acid Sequence; Animals; Base Sequence; BRCA1 Protein; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; DNA Primers; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Glutathione Peroxidase; Humans; Mice; Mice, Knockout; Molecular Sequence Data; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Selenocysteine; Sequence Alignment; Sequence Homology, Amino Acid | 2004 |
Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Breast Neoplasms; Cysteine; Dogs; Female; Liver; Male; Organoselenium Compounds; Rats; Selenocysteine | 2008 |
[Effects of Se-methylselenocysteine on biological behavior of and matrix metalloproteinase-2 expression in human breast cancer MDA-MB-231 cells].
Topics: Anticarcinogenic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cysteine; Female; Humans; Matrix Metalloproteinase 2; Organoselenium Compounds; RNA, Messenger; S Phase; Selenocysteine | 2008 |
Effect of selenium compounds and thiols on human mammary tumor cells.
Topics: Aged; Antimetabolites; Breast Neoplasms; Buthionine Sulfoximine; Cell Survival; Cysteine; Female; Glutathione; Glutathione Peroxidase; Humans; Mercaptoethanol; Methionine Sulfoximine; Organoselenium Compounds; Selenic Acid; Selenious Acid; Selenium; Selenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite; Sulfhydryl Compounds; Trypan Blue; Tumor Cells, Cultured | 1991 |